Literature DB >> 30853302

Aging and the cancer burden in Latin America and the Caribbean: Time to act.

Sophie Pilleron1, Isabelle Soerjomataram2, Enrique Soto-Perez-de-Celis3, Jacques Ferlay2, Enrique Vega4, Freddie Bray2, Marion Piñeros2.   

Abstract

OBJECTIVE: To describe the cancer burden in adults aged 65 years and older in Latin America and the Caribbean to serve as rational for improving cancer control planning among region's older population.
MATERIALS AND METHODS: Using the up-to-date GLOBOCAN estimates for 2018, we describe the cancer burden including key patterns for the major cancer sites among adults aged 65 years and older in Latin America and the Caribbean. We also predict the future burden in 2040 by applying population projections, assuming no changes in incidence rates over time.
RESULTS: In 2018, an estimated 679,000 new cancer cases occurred among older adults in LAC, representing almost half (48%) of the total incidence burden (43% in Central America, 49% in South America, and 52% in the Caribbean). Prostate, colorectum, and lung were the most common cancers among older males in South America and the Caribbean, with non-melanoma skin cancer ranking third in Central America. Among older females, the most common sites were breast, colorectum, and non-melanoma skin cancer, except in the Caribbean, where lung cancer ranked third. Overall, the number of new cancer cases among older adults in the region is expected to double by 2040, reaching 1.6 million new cases.
CONCLUSION: Our findings highlight the need for an urgent adaptation of healthcare systems across LAC by improving training in geriatrics for the oncology workforce, and by including older adults in clinical guidelines, insurance schemes, and cancer prevention policies.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer; Epidemiology; LAC; Older adults

Mesh:

Year:  2019        PMID: 30853302     DOI: 10.1016/j.jgo.2019.02.014

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  6 in total

1.  Current and projected number of years of life lost due to prostate cancer: A global study.

Authors:  Diana Withrow; Sophie Pilleron; Nikita Nikita; Jacques Ferlay; Swapnil Sharma; Brian Nicholson; Timothy R Rebbeck; Grace Lu-Yao
Journal:  Prostate       Date:  2022-04-25       Impact factor: 4.012

2.  Inequity in inequity: Disproportional mortality risk in patients with cancer with COVID-19 in Brazil - a call to action.

Authors:  Gabrielle R Sena; Jurema T O Lima; Tiago P F Lima; Suely A Vidal; Mozart J T Sales; Paulo S A Goes; Maria Julia G Mello
Journal:  J Geriatr Oncol       Date:  2022-05-17       Impact factor: 3.929

3.  AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis.

Authors:  Rafael Adrián Pacheco-Orozco; Lorena Montealegre-Páez; Federico Cayol; Héctor Martínez-Gregorio; Javier Oliver; Cecilia Frecha; Felipe Vaca-Paniagua; Sandra Perdomo
Journal:  Oncologist       Date:  2020-08-19

4.  Barriers and Facilitators for the Implementation of Geriatric Oncology Principles in Mexico: A Mixed-Methods Study.

Authors:  Haydee C Verduzco-Aguirre; Laura M Bolaño Guerra; Eva Culakova; Javier Monroy Chargoy; Hector Martínez-Said; Gregorio Quintero Beulo; Supriya G Mohile; Enrique Soto-Perez-De-Celis
Journal:  JCO Glob Oncol       Date:  2022-03

5.  Epidemiology of Urological Cancers in Brazil: Trends in Mortality Rates Over More Than Two Decades.

Authors:  Thiago Camelo Mourão; Maria Paula Curado; Renato Almeida Rosa de Oliveira; Thiago Borges Marques Santana; Ricardo de Lima Favaretto; Gustavo Cardoso Guimarães
Journal:  J Epidemiol Glob Health       Date:  2022-05-31

6.  Genomic Diversity in Sporadic Breast Cancer in a Latin American Population.

Authors:  Lucía Brignoni; Mónica Cappetta; Valentina Colistro; Mónica Sans; Nora Artagaveytia; Carolina Bonilla; Bernardo Bertoni
Journal:  Genes (Basel)       Date:  2020-10-28       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.